NCT02598219 2026-03-18
SENTIRAD
Centre Oscar Lambret
Phase 3 Active not recruiting
Clinical Trials
11 trialsNCT03875820 2026-03-10
FRAME
Institute of Cancer Research, United Kingdom
Phase 1 Active not recruiting
NCT04065269 2026-02-20
ATARI
Institute of Cancer Research, United Kingdom
Phase 2 Active not recruiting
NCT04458597 2025-08-01
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT06549855 2024-08-12
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT06468215 2024-07-16
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT05080556 2024-04-12
ACTOv
University College, London
Phase 2 Recruiting
NCT05945407 2023-07-14
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Peking University People's Hospital
Phase NA Recruiting
NCT02728258 2022-02-15
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
NRG Oncology
Phase 2 Completed
NCT04498520 2021-05-18
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
University of California, San Francisco
Phase 1 Withdrawn
NCT02093598 2020-11-27
POEM
MedSIR
Phase 2 Completed